Thermo Fisher Scientific Inc., a leader in its industry, offers diverse life sciences solutions and services that cater to a range of markets worldwide. Despite current market volatility, TMO remains stable with promising prospects due to its diversified portfolio and strong market position.
The company's fundamentals indicate a stable financial health with room for improvement. Its diversified segments perform consistently, supporting its growth outlook.
Category | Score | Visual Score |
---|---|---|
Discounted Cash Flow | 5 | |
Return on Equity | 4 | |
Return on Assets | 5 | |
Debt to Equity | 1 | |
Price to Earnings | 1 | |
Price to Book | 2 |
The historical analysis shows consistent performance, with the latest data pointing to stability amidst minor fluctuations in overall scores.
Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
---|---|---|---|---|---|---|---|
2025-06-13 | 3 | 5 | 4 | 5 | 1 | 1 | 2 |
Previous | 0 | 5 | 4 | 5 | 1 | 1 | 2 |
Analyst estimates suggest a positive outlook, with the consensus price target reflecting confidence in Thermo Fisher's growth trajectory.
High | Low | Median | Consensus |
---|---|---|---|
693 | 585 | 607.5 | 623.25 |
The strong 'Buy' recommendations highlight a robust investor sentiment and suggest potential appreciation in TMO's stock price.
Recommendation | Number | Distribution |
---|---|---|
Strong Buy | 0 | |
Buy | 34 | |
Hold | 7 | |
Sell | 0 | |
Strong Sell | 0 |
Thermo Fisher Scientific Inc. demonstrates financial health and growth potential supported by its diversified operations. While certain metrics like Debt to Equity and Price to Earnings indicate areas for improvement, the strong analyst sentiment and robust price targets suggest a positive outlook. Investors may find the current price levels attractive with an expectation of future growth. However, macroeconomic conditions and sector-specific challenges should be monitored for potential impact.